Audience litigation face European Commission (CE) and pharmaceutical AstraZeneca Due to the delayed delivery of the vaccine against Covid-19, May 26 In the civil court of first instance in Brussels.
There is one this Wednesday At first glanceAbout 35 minutes later, after the community executive asked last Friday, the parties and the judge determined Process schedule judicial.
However, when introducing the process, the lawyers of the European Community Paul Alain Soriers and Rafaël Jafferali asked for an accelerated resolution of the case, and AstraZeneca (AstraZeneca) Hakim Boularbah, It takes “time” to deal with technically complex cases.
“Everyday is important”In front of Judge Jafferali, it was stated that ensuring the contract with the pharmaceutical company was “for Use many production sites where AstraZeneca is still in breach of contract“.
Jafferali did not express the claims made by the European Commission and member states to the EU, but European sources pointed out that Brussels is not seeking financial compensation, but the dose that AstraZeneca has not yet delivered.
A lawyer from the office of Simant Braun pointed out: “It is important to close the first phase of vaccination as soon as possible to promote economic growth as soon as possible.” As he said, Brussels I expect 30 million doses of AstraZeneca in December and other months 100 at the end of the first three months. The calendar is not respected.Anglo-Swiss Pharmacy 29.8 million delivered It is estimated that 300 million doses will be injected in the first quarter of 2021, and a total of 100 million doses are expected to be injected by the end of June. In contrast, the total expected dose is 300 million doses.
AstraZeneca lawyer, Is the person who defended Belgium and Spain in the lawsuit of the former Catalan president Karls Pigment He appealed to Supreme Court Judge Pablo Llarena (Pablo Llarena) in the country and lost to him. He pointed out that after some fatal thrombosis, EU countries hardly resorted to his clients. vaccine.
In front of the media, the lawyer pointed out in a public hearing that AstraZeneca rejected the committee’s argument that the contract had been violated and stated that it would, based on the source of the contract, Non-profit role Anglo Sweden Laboratory and Complexity of the production process vaccine.